ZIA BC 011853 (ZIA) | |||
---|---|---|---|
Title | CONNECT: Comprehensive Oncology Network Evaluating Rare CNS Tumors - Cures | ||
Institution | NCI, Bethesda, MD | ||
Principal Investigator | Gilbert, Mark | NCI Program Director | N/A |
Cancer Activity | N/A | Division | CCR |
Funded Amount | $381,941 | Project Dates | null - null |
Fiscal Year | 2018 | Project Type | Intramural |
Research Topics w/ Percent Relevance | Cancer Types w/ Percent Relevance | ||
Cancer (100.0%) |
Brain (100.0%) Nervous System (100.0%) |
||
Research Type | |||
N/A | |||
Abstract | |||
During this year, steps were taken to build the infrastructure required to start building this network. In addition, the inaugural NCI-CONNECT meeting was held in June 2018 in conjunction with the Brain Tumor Trials Collaborative (BTTC) Annual Meeting. The goal of the meetings were to bring together leaders in neuro-oncology clinical care, basic science and clinical research with advocacy partners in a collegial and collaborative environment to discuss current and future brain tumor clinical trials. Attendees shared new clinical trial concepts that had both high levels of scientific merit and also incorporated measures of patient quality of life and outcomes. The aim is to help advance treatments for patients with malignant brain tumors, with a particular focus on rare tumors of the central nervous system. Furthermore, NCI-CONNECT been working on opening a number of studies for adult patients with rare central nervous system cancers. |